“Beta-glucan” is not one ingredient. The soluble fibre from oats and barley, and the branched glucan from baker’s yeast or mushrooms, are structurally different molecules with different evidence, different regulatory histories and different uses in a formula. Brands abroad sometimes ask for “beta-glucan” without specifying which one, and the two are not interchangeable in either evidence or wording.

This guide keeps the two families separate throughout, sets out what each has been studied for, and what to decide before a Japan-made product.

Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.

💬 Planning a beta-glucan product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.

What the research shows

Oat and barley beta-glucan is a soluble fibre studied mainly for gut fermentation and blood markers, while yeast and mushroom beta-glucan is a different, insoluble structure studied mainly for immune markers.

StudyDesign/What was analysedReported result
Uncontrolled before-and-after pilot study, PLoS One 2017 (PMID 28107445)26 healthy adults, no control group, 2 months of pasta enriched with barley beta-glucan (3 g/100 g)Gut short-chain fatty acid production increased, serum LDL and total cholesterol fell, and endothelial vascular reactivity improved versus baseline
Randomised, double-blind, placebo-controlled trial, Nutrition 2017 (PMID 28606567)98 adults aged 50–70, 250 mg/day yeast beta-1,3/1,6-glucan for 90 days over winterFewer upper respiratory infections in the glucan group, but the difference from placebo did not reach statistical significance (P=0.149); some immune cytokine markers changed significantly
Randomised, double-blind, placebo-controlled, multicentric trial, European Journal of Nutrition 2013 (PMID 23340963)162 healthy adults with recurring infections, 900 mg/day insoluble yeast beta-1,3/1,6-glucan for 16 weeksSymptomatic common cold infections were 25% fewer than placebo (P=0.041); sleep difficulty during a cold episode was significantly reduced

Every study above used a different source, dose and outcome, which is the central point of this ingredient: a barley-glucan gut/cholesterol result cannot be used to support a claim about a yeast-glucan immune product, and vice versa. All three studies were in generally healthy adults, and the barley study had no control group, so its changes cannot be separated from other influences over the two months; none supports a disease-related claim, and none should be read as evidence for a different beta-glucan source than the one tested.

Checked against the published abstracts on 25 September 2026.

What Japanese products say

In Japan, barley- and oat-derived beta-glucan has its own Foods with Function Claims notifications, separate from yeast- or mushroom-derived beta-glucan.

Barley beta-glucan is notified in Japan’s Foods with Function Claims system by several companies, with functions relating to the after-meal blood glucose response and to blood cholesterol levels, evidenced and dosed for that specific fibre. Yeast-derived beta-glucan is a newer entrant to the same system, generally notified for narrower functions such as everyday fatigue. Confirm the current notification for the specific source you plan to use — a notification for one source is not evidence for the other.

In the European Union, beta-glucans from oats or barley carry an authorised health claim under Regulation (EU) No 432/2012: the wording “Beta-glucans contribute to the maintenance of normal blood cholesterol levels” may be used on food that contains at least 1 g of beta-glucan from oats, oat bran, barley, barley bran or a mixture of these per quantified portion, with the label stating that the beneficial effect requires a daily intake of 3 g. This is a fact about EU food law for the fibre itself, tied to specific minimum amounts on specific foods — it is not a claim this guide makes for any particular product, and it does not apply to yeast- or mushroom-derived beta-glucan at all.

💬 Need help keeping oat/barley and yeast/mushroom beta-glucan properly separated in your dossier? We prepare the documentation with the manufacturing specification. Tell us your market.

Wording that stays on safe ground

Always name the source, and never borrow a regulatory fact about the fibre as if it were a claim for your finished product.

Safer wordingWording to avoid
”Contains oat/barley beta-glucan, a soluble dietary fibre”Using an EU or Japanese regulatory claim as your own marketing line without meeting its exact conditions
”Contains yeast beta-glucan, studied for immune-marker changes in small trials”Treating yeast beta-glucan evidence as if it applied to oat or barley beta-glucan
Naming the source (oat, barley, yeast, mushroom) every time “beta-glucan” appears”Beta-glucan” alone, leaving the source unstated

How beta-glucan is formulated

Oat/barley beta-glucan is typically a coarse soluble-fibre powder dosed in grams; yeast/mushroom beta-glucan is a finer, purified powder dosed in milligrams.

Dosage formWhy brands choose itWhat to weigh up
Powder or drink mix (oat/barley)Matches the multi-gram daily amount used in cholesterol/glucose researchViscosity and mouthfeel when mixed with liquid
Baked good or cereal format (oat/barley)A familiar delivery format for a fibre ingredientBeta-glucan content can vary with processing; specify the guaranteed content
Capsule or tablet (yeast/mushroom)Matches the smaller milligram doses used in immune researchPurity grade and molecular structure (1,3/1,6-linkage) affect the evidence that applies

Decisions that shape the specification:

  1. Source and molecular structure. State explicitly whether the beta-glucan is from oats, barley, baker’s yeast or mushroom, and its beta-1,3/1,6 or beta-1,3/1,4 linkage — these are not interchangeable specifications.
  2. Guaranteed beta-glucan content. For oat/barley fibre, ask the supplier for the beta-glucan content of the finished ingredient, since it varies with the grain and processing.
  3. Amount per serving. Match the amount to any study you intend to cite — the gram-level oat/barley doses and the milligram-level yeast/mushroom doses are not comparable.
  4. Companion ingredients. Beta-glucan is often combined with other fibres or with immune-positioned botanicals; each needs its own check against Japanese food law.
  5. Your market’s status for the specific source. Confirm the regulatory status of oat/barley beta-glucan separately from yeast/mushroom beta-glucan in your own market before you commit to a formula.

The check that comes first

Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.

Oat, barley, yeast and mushroom-derived beta-glucan are all established as foods in Japan. Where a formula blends beta-glucan with other fibres or botanicals, each addition needs its own check. See the Japan-made supplement OEM page, and our dietary fibre guide for a related gut-focused ingredient.

Before you ask for a quotation

A factory can quote accurately once the source, the amount, the form and the packaging are fixed.

  • Beta-glucan source (oat, barley, yeast, mushroom) and guaranteed content
  • Amount per serving and servings per pack
  • Dosage form (powder, capsule, tablet, baked/cereal format)
  • Companion ingredients and their amounts
  • Packaging
  • Countries you will sell in, and that source’s status there
  • First order and annual volume

💬 Ready to design a Japan-made beta-glucan product? Send us the concept — source, amount, form and the countries you will sell in.

Frequently asked questions

1. Is beta-glucan from oats the same as beta-glucan from yeast?
No. They are structurally different molecules — oat/barley beta-glucan is a soluble fibre with a 1,3/1,4 linkage, while yeast and mushroom beta-glucan has a 1,3/1,6 linkage. Evidence, doses and regulatory claims for one do not transfer to the other.

2. What does the research support for oat or barley beta-glucan?
Small studies, including an uncontrolled pilot study, link it to increased gut short-chain fatty acid production and changes in blood lipid markers, at gram-level daily doses. The European Union has an authorised claim about blood cholesterol maintenance for oat/barley beta-glucan specifically, tied to a minimum content and a 3 g daily intake — a regulatory fact about the fibre, not a claim we make for any product.

3. What does the research support for yeast or mushroom beta-glucan?
Small trials at milligram-level doses report immune-marker changes and, in one 16-week trial, fewer symptomatic cold infections than placebo. A 90-day trial in older adults found a similar trend that did not reach statistical significance. These are modest, source-specific findings.

4. Can I put a cholesterol claim on my product?
That depends entirely on your market’s rules and on meeting the exact conditions those rules set (ingredient, source, minimum content, daily intake) — it is not something to assume from a general “beta-glucan” ingredient list. Check with your regulatory adviser before using any such claim.

5. Which dosage form suits beta-glucan?
It depends on the source. Oat/barley beta-glucan is usually a powder or baked/cereal format at gram-level doses; yeast/mushroom beta-glucan is usually a capsule or tablet at milligram-level doses.


Sources: “Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals”, PLoS One 2017 (PMID 28107445); “Yeast-derived β-1,3/1,6 glucan, upper respiratory tract infection and innate immunity in older adults”, Nutrition 2017 (PMID 28606567); “Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body’s defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects”, European Journal of Nutrition 2013 (PMID 23340963); Commission Regulation (EU) No 432/2012, Annex, entry for beta-glucans; Consumer Affairs Agency notifications for Foods with Function Claims. Checked on 12 October 2026.